Shock Trial Flips Depression Playbook

Person lying on a bed with a pillow over their head, surrounded by medication

Most depression treatments try to kill the pain — but a new therapy tries to build joy instead, and the results are turning heads in clinical research.

Quick Take

Positive Affect Treatment (PAT) targets the brain’s reward system to grow positive emotions, not just reduce negative ones.
A clinical trial published in JAMA Network Open found PAT outperformed a negative-affect-focused therapy on depression, anxiety, stress, and suicidal thoughts.
PAT showed stronger results on reward sensitivity — the brain’s ability to feel motivated and anticipate pleasure — than the comparison therapy.
Researchers caution the evidence is still early, and larger trials are needed before PAT becomes a standard treatment.

Depression Treatment Has Long Ignored the Pleasure Side of the Brain

For decades, most depression therapies have worked the same basic way. They try to reduce fear, worry, sadness, and negative thinking. That approach helps many people. But it leaves out something important. A large portion of people with depression don’t just feel too much pain — they feel too little joy. They lose the ability to look forward to things, feel motivated, or enjoy life. That symptom has a name: anhedonia. And standard therapies often barely touch it.

Positive Affect Treatment, or PAT, was built to fix that gap. Developed by researchers at UCLA, PAT uses structured exercises to rebuild the brain’s reward system. Patients practice noticing pleasure, building anticipation, and savoring good moments. The goal is not just to feel less bad — it’s to feel genuinely good again. That distinction sounds simple, but it points to a very different idea about what depression actually is and how to fight it.

What the Clinical Trial Actually Found

A randomized clinical trial published in JAMA Network Open put PAT head-to-head against a therapy focused on reducing negative emotions. Researchers enrolled adults with moderate-to-severe depression, anxiety, and low positive mood. The results favored PAT across multiple measures. Patients who received PAT showed greater improvements in positive feelings, depression severity, anxiety, stress, and suicidal thinking at a six-month follow-up. ^[7] That’s a broad set of wins for a single therapy approach.

The trial also tested whether PAT actually changed the brain mechanisms it was designed to target. It did. ^[4] Patients in the PAT group showed stronger gains in reward sensitivity — meaning their brains got better at processing motivation and anticipating good outcomes. That matters because it suggests PAT isn’t just helping people feel better in the moment. It may be rewiring how the brain responds to positive experiences over time. That kind of mechanistic evidence gives the findings more credibility than symptom scores alone.

The Honest Limits of What We Know So Far

The science is promising, but it’s still early. The trial that produced these results was well-designed, but it was a single study with a limited sample size. Depression research has a long history of therapies that looked great in early trials and then faded under broader testing. PAT has not yet been tested in large, multi-site trials across diverse populations. ^[3] Until that happens, calling it a superior treatment to everything else would be getting ahead of the evidence. Cautious optimism is the right posture here.

There’s also a practical challenge the research hints at. Some people actually fear positive emotions. ^[6] They worry that feeling good will lead to disappointment, or that happiness is somehow unsafe. For those patients, a therapy built entirely around building joy could hit unexpected resistance. PAT’s designers are aware of this, but it’s a real-world complication that clinical trials don’t always capture well. Therapists using PAT in practice will need to navigate that barrier carefully with certain patients.

Why This Approach Deserves More Attention and Funding

Depression affects roughly one in five Americans at some point in their lives. Current treatments — medication, talk therapy, or both — fail a significant share of patients. Many people go through multiple rounds of treatment and still struggle. A therapy that directly targets the reward system offers a fresh angle. If larger trials confirm what early research shows, PAT could become a meaningful option for the millions of people who have tried standard care and found it lacking. ^[5] That’s a big population worth fighting for.

The core idea behind PAT also aligns with something common sense already suggests. Helping someone feel more joy, purpose, and motivation isn’t a soft or secondary goal — it’s the whole point of treating depression. Focusing only on reducing suffering while ignoring the restoration of positive experience has always been an incomplete strategy. PAT doesn’t replace the need to address pain. But it adds something that most therapies skip entirely. For patients stuck in a gray, joyless fog, that addition could make all the difference. ^[8]